Bailard »

Astria Therapeutics shares owned by Bailard

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2025-09-30 $193k 27k 7.28
2025-06-30 $142k 27k 5.36

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
Vestal Point Capital
Fcpm Iii Services B.v.
Fairmount Funds Management
BlackRock
Millennium Management
TCG Crossover Management
Vanguard Group
VR Adviser
Jpmorgan Chase & Co
Vivo Capital
Rosalind Advisors
Driehaus Capital Management
Nantahala Capital Management

View all funds holding Astria Therapeutics